Ex vivo rehabilitation of non–heart-beating donor lungs in preclinical porcine model: Delayed perfusion results in superior lung function

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 5, 2012, Pages 1208-1216

  Mulloy, Daniel P ^a   Stone, Matthew L ^a   Crosby, Ivan K ^a   LaPar, Damien J ^a   Sharma, Ashish K ^a   Webb, David V ^a   Lau, Christine L ^a   Laubach, Victor E ^a   Kron, Irving L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR AGONIST; CEFAZOLIN; HEPARIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR; AUTACOID; CITRIC ACID; PERFADEX; PRESERVATION SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD OXYGENATION; BREATHING RATE; COLD ISCHEMIA; COLD STATIC PRESERVATION; CONTROLLED STUDY; DOMESTIC PIG; EX VIVO STUDY; FEMALE; FUNCTIONAL STATUS; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; LEFT LUNG; LUNG ARTERY PRESSURE; LUNG DONOR; LUNG FUNCTION; LUNG INJURY; LUNG INJURY SEVERITY SCORE; LUNG PERFUSION; LUNG PRESERVATION; LUNG TRANSPLANTATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; OXYGENATION; PORCINE MODEL; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REHABILITATION CARE; REPERFUSION; REPERFUSION INJURY; TIDAL VOLUME; ANIMAL; ARTERIAL PRESSURE; COLD; COMPARATIVE STUDY; DISEASE MODEL; DONOR; DRUG EFFECT; HEART ARREST; IMMUNOLOGY; ISCHEMIA; LUNG; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PERFUSION; PULMONARY ARTERY; SWINE; TIME;

ANIMALS; ARTERIAL PRESSURE; CITRATES; COLD ISCHEMIA; COLD TEMPERATURE; DISEASE MODELS, ANIMAL; FEMALE; HEART ARREST; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-8; LUNG; LUNG TRANSPLANTATION; MALE; ORGAN PRESERVATION SOLUTIONS; PERFUSION; PULMONARY ARTERY; PULMONARY GAS EXCHANGE; REPERFUSION INJURY; RESPIRATORY FUNCTION TESTS; SUS SCROFA; TIME FACTORS; TISSUE DONORS; TUMOR NECROSIS FACTOR-ALPHA; WARM ISCHEMIA;

EID: 85027951934     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.07.056     Document Type: Article

References (26)

1. Kootstra, G., Daemen, J.H., Oomen, A.P., Categories of non-heart-beating donors. Transplant Proc 27 (1995), 2893–2894.
2. de Antonio, D.G., Marcos, R., Laporta, R., Mora, G., Garcia-Gallo, C., Gamez, P., et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant 26 (2007), 529–534.
3. Gomez-de-Antonio, D., Campo-Canaveral, J.L., Crowley, S., Valdivia, D., Cordoba, M., Moradiellos, J., et al. Clinical lung transplantation from uncontrolled non-heart-beating donors revisited. J Heart Lung Transplant 31 (2012), 349–353.
4. Wigfield, C.H., Love, R.B., Donation after cardiac death lung transplantation outcomes. Curr Opin Organ Transplant 16 (2011), 462–468.
5. Steen, S., Sjoberg, T., Pierre, L., Liao, Q., Eriksson, L., Algotsson, L., Transplantation of lungs from a non-heart-beating donor. Lancet 357 (2001), 825–829.
6. Cypel, M., Yeung, J.C., Hirayama, S., Rubacha, M., Fischer, S., Anraku, M., et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 27 (2008), 1319–1325.
7. Cypel, M., Rubacha, M., Yeung, J., Hirayama, S., Torbicki, K., Madonik, M., et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 9 (2009), 2262–2269.
8. Cypel, M., Yeung, J.C., Liu, M., Anraku, M., Chen, F., Karolak, W., et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 364 (2011), 1431–1440.
9. LaPar, D.J., Laubach, V.E., Emaminia, A., Crosby, I.K., Hajzus, V.A., Sharma, A.K., et al. Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model. J Thorac Cardiovasc Surg 142 (2011), 887–894.
10. Emaminia, A., Lapar, D.J., Zhao, Y., Steidle, J.F., Harris, D.A., Laubach, V.E., et al. Adenosine A(2)A agonist improves lung function during ex vivo lung perfusion. Ann Thorac Surg 92 (2011), 1840–1846.
11. Gazoni, L.M., Laubach, V.E., Mulloy, D.P., Bellizzi, A., Unger, E.B., Linden, J., et al. Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg 135 (2008), 156–165.
12. Gazoni, L.M., Walters, D.M., Unger, E.B., Linden, J., Kron, I.L., Laubach, V.E., Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia–reperfusion injury. J Thorac Cardiovasc Surg 140 (2010), 440–446.
13. Sharma, A.K., Laubach, V.E., Ramos, S.I., Zhao, Y., Stukenborg, G., Linden, J., et al. Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia–reperfusion injury. J Thorac Cardiovasc Surg 139 (2010), 474–482.
14. Koroskenyi, K., Duro, E., Pallai, A., Sarang, Z., Kloor, D., Ucker, D.S., et al. Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation. J Immunol 186 (2011), 7144–7155.
15. Linden, J., Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41 (2001), 775–787.
16. Lisle, T.C., Gazoni, L.M., Fernandez, L.G., Sharma, A.K., Bellizzi, A.M., Schifflett, G.D., et al. Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A(2A) receptor activation. J Thorac Cardiovasc Surg 136 (2008), 1280–1288.
17. Snell, G.I., Rabinov, M., Griffiths, A., Williams, T., Ugoni, A., Salamonsson, R., et al. Pulmonary allograft ischemic time: an important predictor of survival after lung transplantation. J Heart Lung Transplant 15 (1996), 160–168.
18. Thabut, G., Mal, H., Cerrina, J., Dartevelle, P., Dromer, C., Velly, J.F., et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 171 (2005), 786–791.
19. Ingemansson, R., Eyjolfsson, A., Mared, L., Pierre, L., Algotsson, L., Ekmehag, B., et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 87 (2009), 255–260.
20. Weng, Y., Sun, S., Therapeutic hypothermia after cardiac arrest in adults: mechanism of neuroprotection, phases of hypothermia, and methods of cooling. Crit Care Clin 28 (2012), 231–243.
21. Lampe, J.W., Becker, L.B., State of the art in therapeutic hypothermia. Annu Rev Med 62 (2011), 79–93.
22. Globus, M.Y., Busto, R., Lin, B., Schnippering, H., Ginsberg, M.D., Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation. J Neurochem 65 (1995), 1250–1256.
23. Yang, D., Guo, S., Zhang, T., Li, H., Hypothermia attenuates ischemia/reperfusion-induced endothelial cell apoptosis via alterations in apoptotic pathways and JNK signaling. FEBS Lett 583 (2009), 2500–2506.
24. Akriotis, V., Biggar, W.D., The effects of hypothermia on neutrophil function in vitro. J Leukoc Biol 37 (1985), 51–61.
25. Dempsey, R.J., Combs, D.J., Maley, M.E., Cowen, D.E., Roy, M.W., Donaldson, D.L., Moderate hypothermia reduces postischemic edema development and leukotriene production. Neurosurgery 21 (1987), 177–181.
26. Fischer, S., Renz, D., Wiesnet, M., Schaper, W., Karliczek, G.F., Hypothermia abolishes hypoxia-induced hyperpermeability in brain microvessel endothelial cells. Brain Res Mol Brain Res 74 (1999), 135–144.